RECENT COMMENTS

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Rajesh Kumar: Please write your comment here   »Read more

christian: Is gabapentin has been proposed to treat peripheric neuropathy induced by chemotherapy. At low dosa [...]   »Read more

Best Cancer Reporter Award

Issue 44
The future of cancer as told through the story of Renee
Issue 41
Think before you ruin your patient's chance of parenthood
Issue 40
Desperately seeking a bone marrow match
Issue 39
Shining a light on nanoparticle therapy
Issue 38
Prize for journalists who tackled the taboo subject of rationing cancer therapies
Issue 34
Ten years reporting from the frontline: American journalist wins award for her coverage
Issue 33
The 'no miracle cure' story
Issue 32
Are we educating women to be afraid? UK health reporter questions the value of simplistic screening messages
Issue 28
Everyone deserves the best chance to survive
Issue 27
If nothing is done....Prize-winning article tells the story behind falling cancer mortality rates
Issue 26
The neglected magic bullet
Issue 24
"There's a shadow in your head"
Issue 23
Make prevention easy
Issue 22
My wife has breast cancer...
Issue 21
Do-it-yourself Chemotherapy Access
Issue 20
Polish reporter wins ESO award for coverage of colonscopy screening
Issue 16
From plan to practise
Issue 15
Reporting cancer from the inside
The subject is complex, the story is clear
Issue 14
Guardian journalist named Best Cancer Reporter
Issue 9
How the hostage-taking of Twist hit the mass media
Issue 8
Award for journalist who exposed failings in Hungary's cancer services

 
 

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR16 - Cardiac side effects of molecular targeted therapies: Towards a better dialogue between oncologists and cardiologists (based on a review article of Critical Reviews in Oncology Hematology)

GR182 - Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers

GR183 - The current management of low-grade glioma in childhood

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.